Published in
Nature Research, npj Breast Cancer, 1(9), 2023
DOI: 10.1038/s41523-023-00532-3
Links
Tools
Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial
Journal article published in 2023 by
Maria Vittoria Dieci 
,
Giancarlo Bisagni,
Stefania Bartolini ,
Antonio Frassoldati ,
Roberto Vicini ,
Sara Balduzzi ,
Roberto D’amico,
Pierfranco Conte,
Valentina Guarneri
,
Giancarlo Bisagni,
Stefania Bartolini ,
Antonio Frassoldati ,
Roberto Vicini ,
Sara Balduzzi ,
Roberto D’amico,
Pierfranco Conte,
Valentina Guarneri
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 